Top ▲
Gene and Protein Information | ||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | 4 | 254 | 7q22.1 | ORAI2 | ORAI calcium release-activated calcium modulator 2 | |
Mouse | 4 | 250 | 5 G2 | Orai2 | ORAI calcium release-activated calcium modulator 2 | |
Rat | 4 | - | 12q12 | Orai2 | ORAI calcium release-activated calcium modulator 2 |
Previous and Unofficial Names |
CAP-binding protein complex interacting protein 2 | CBCIP2 | TMEM142B |
Database Links | |
Alphafold | Q96SN7 (Hs), Q8BH10 (Mm) |
ChEMBL Target | CHEMBL4888450 (Hs) |
Ensembl Gene | ENSG00000160991 (Hs), ENSMUSG00000039747 (Mm), ENSRNOG00000001427 (Rn) |
Entrez Gene | 80228 (Hs), 304592 (Rn) |
Human Protein Atlas | ENSG00000160991 (Hs) |
KEGG Gene | hsa:80228 (Hs), rno:304592 (Rn) |
OMIM | 610929 (Hs) |
Pharos | Q96SN7 (Hs) |
RefSeq Nucleotide | NM_032831 (Hs), NM_178751 (Mm), NM_001170403 (Rn) |
RefSeq Protein | NP_001119812 (Hs), NP_848866 (Mm), NP_001163874 (Rn) |
UniProtKB | Q96SN7 (Hs), Q8BH10 (Mm) |
Wikipedia | ORAI2 (Hs) |
Download all structure-activity data for this target as a CSV file
Channel Blockers | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Immunopharmacology Comments |
The ORAI1 and ORAI2 proteins form heteromeric complexes that constitute the pore of Ca2+ release-activated Ca2+ (CRAC) channels. CRAC channels mediate store-operated Ca2+ entry (SOCE), a function that is essential for proper T cell function. Evidence indicates that ORAI2 fine-tunes SOCE to modulate the immune response [3]. Mice with double Orai1/Orai2 knockout have severely impaired T cell function and T cell-dependent antiviral immune responses. Conversely, these mice are protected from T cell-mediated autoimmunity and alloimmunity. |
Cell Type Associations | ||||||
|
Physiological Consequences of Altering Gene Expression | ||||||||||
|
||||||||||
|
1. Tsvilovskyy V, Solís-López A, Schumacher D, Medert R, Roers A, Kriebs U, Freichel M. (2018) Deletion of Orai2 augments endogenous CRAC currents and degranulation in mast cells leading to enhanced anaphylaxis. Cell Calcium, 71: 24-33. [PMID:29604961]
2. Vaeth M, Feske S. (2018) Ion channelopathies of the immune system. Curr Opin Immunol, 52: 39-50. [PMID:29635109]
3. Vaeth M, Yang J, Yamashita M, Zee I, Eckstein M, Knosp C, Kaufmann U, Karoly Jani P, Lacruz RS, Flockerzi V et al.. (2017) ORAI2 modulates store-operated calcium entry and T cell-mediated immunity. Nat Commun, 8: 14714. [PMID:28294127]
4. Velicelebi G, Stauderman K, Dunn M, Roos J. (2016) Pancreatitis treatment. Patent number: WO2016138472A1. Assignee: Calcimedica, Inc.. Priority date: 27/02/2015. Publication date: 01/09/2016.
Orai channels: Orai2. Last modified on 11/01/2021. Accessed on 11/10/2024. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetoimmunopharmacology.org/GRAC/ObjectDisplayForward?objectId=2965.